Case Report: A good response to furmonertinib second-line treatment of an advanced lung adenocarcinoma patient with a rare EGFR exon 20 N771_P772insH mutation: A case report and literature review

Background: Lung adenocarcinoma with the classical EGFR 19 deletion and exon 21 L858R point mutations has exhibited good responses to epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) treatment. However, the sensitivity of uncommon EGFR exon 20 insertion mutation to third-gener...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Xiao Zhang (Autor), Huan Han (Autor), Jiuzhou Zhao (Autor), Xiao Liu (Autor), Jianbo Zhang (Autor), Rui Sun (Autor), Shaomei Li (Autor), Baoxing Liu (Autor), Hui Zhu (Autor), Shuyue Jiao (Autor), Xiang Li (Autor), Hong Tang (Autor)
Format: Knjiga
Izdano: Frontiers Media S.A., 2022-08-01T00:00:00Z.
Teme:
Online pristup:Connect to this object online.
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Internet

Connect to this object online.

3rd Floor Main Library

Detalji primjeraka od 3rd Floor Main Library
Signatura: A1234.567
Primjerak 1 Dostupno